
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1401733
[patent_doc_number] => 06538022
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors)'
[patent_app_type] => B1
[patent_app_number] => 09/252063
[patent_app_country] => US
[patent_app_date] => 1999-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 37046
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/538/06538022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09252063
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/252063 | Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) | Feb 17, 1999 | Issued |
Array
(
[id] => 4423402
[patent_doc_number] => 06225460
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Nucleotide analogs'
[patent_app_type] => 1
[patent_app_number] => 9/247497
[patent_app_country] => US
[patent_app_date] => 1999-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 70958
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225460.pdf
[firstpage_image] =>[orig_patent_app_number] => 247497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/247497 | Nucleotide analogs | Feb 9, 1999 | Issued |
Array
(
[id] => 1507762
[patent_doc_number] => 06440937
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Dipeptide benzamidine as a kininogenase inhibitor'
[patent_app_type] => B1
[patent_app_number] => 09/242126
[patent_app_country] => US
[patent_app_date] => 1999-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440937.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242126
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242126 | Dipeptide benzamidine as a kininogenase inhibitor | Feb 9, 1999 | Issued |
Array
(
[id] => 1426379
[patent_doc_number] => 06504005
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Long-acting drugs and pharmaceutical compositions comprising them'
[patent_app_type] => B1
[patent_app_number] => 09/242026
[patent_app_country] => US
[patent_app_date] => 1999-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12894
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/504/06504005.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242026
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242026 | Long-acting drugs and pharmaceutical compositions comprising them | Feb 4, 1999 | Issued |
Array
(
[id] => 1383711
[patent_doc_number] => 06551999
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-22
[patent_title] => 'Angiogenesis inhibitor'
[patent_app_type] => B1
[patent_app_number] => 09/243822
[patent_app_country] => US
[patent_app_date] => 1999-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 23104
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/551/06551999.pdf
[firstpage_image] =>[orig_patent_app_number] => 09243822
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/243822 | Angiogenesis inhibitor | Feb 2, 1999 | Issued |
| 09/241876 | CATALYTIC ANTIBODIES WHICH HYDROLYZE PRIMARY AMIDES AND METHODS FOR ELICITING SUCH ANTIBODIES | Feb 1, 1999 | Abandoned |
Array
(
[id] => 1479445
[patent_doc_number] => 06451973
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Anilinopeptide derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/214959
[patent_app_country] => US
[patent_app_date] => 1999-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30914
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451973.pdf
[firstpage_image] =>[orig_patent_app_number] => 09214959
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/214959 | Anilinopeptide derivatives | Jan 31, 1999 | Issued |
Array
(
[id] => 4188753
[patent_doc_number] => 06160176
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Anticoagulant agents'
[patent_app_type] => 1
[patent_app_number] => 9/237011
[patent_app_country] => US
[patent_app_date] => 1999-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15780
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/160/06160176.pdf
[firstpage_image] =>[orig_patent_app_number] => 237011
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/237011 | Anticoagulant agents | Jan 24, 1999 | Issued |
Array
(
[id] => 4306600
[patent_doc_number] => 06252041
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Depsipeptides containing non-natural amino acids'
[patent_app_type] => 1
[patent_app_number] => 9/235479
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16294
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 700
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/252/06252041.pdf
[firstpage_image] =>[orig_patent_app_number] => 235479
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235479 | Depsipeptides containing non-natural amino acids | Jan 21, 1999 | Issued |
Array
(
[id] => 1589795
[patent_doc_number] => 06482920
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents'
[patent_app_type] => B1
[patent_app_number] => 09/147573
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10157
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482920.pdf
[firstpage_image] =>[orig_patent_app_number] => 09147573
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147573 | Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | Jan 21, 1999 | Issued |
Array
(
[id] => 1063242
[patent_doc_number] => 06849712
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-01
[patent_title] => 'Peptides with β1 integrin subunit dependent cell adhesion modulating activity'
[patent_app_type] => utility
[patent_app_number] => 09/600432
[patent_app_country] => US
[patent_app_date] => 1999-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7033
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849712.pdf
[firstpage_image] =>[orig_patent_app_number] => 09600432
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/600432 | Peptides with β1 integrin subunit dependent cell adhesion modulating activity | Jan 20, 1999 | Issued |
Array
(
[id] => 1470144
[patent_doc_number] => 06407065
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'VLA-4 antagonists'
[patent_app_type] => B1
[patent_app_number] => 09/233517
[patent_app_country] => US
[patent_app_date] => 1999-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10630
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407065.pdf
[firstpage_image] =>[orig_patent_app_number] => 09233517
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233517 | VLA-4 antagonists | Jan 18, 1999 | Issued |
| 09/228021 | GEL-FORMING POLYPEPTIDE DERIVATIVES | Jan 10, 1999 | Abandoned |
Array
(
[id] => 1418658
[patent_doc_number] => 06512118
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-28
[patent_title] => 'Camptothecin derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/227158
[patent_app_country] => US
[patent_app_date] => 1999-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11419
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/512/06512118.pdf
[firstpage_image] =>[orig_patent_app_number] => 09227158
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/227158 | Camptothecin derivatives | Jan 7, 1999 | Issued |
Array
(
[id] => 1005601
[patent_doc_number] => 06906198
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-14
[patent_title] => 'Antipicornaviral compounds, their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 09/647712
[patent_app_country] => US
[patent_app_date] => 1999-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44811
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906198.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647712
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647712 | Antipicornaviral compounds, their preparation and use | Jan 4, 1999 | Issued |
Array
(
[id] => 1282761
[patent_doc_number] => 06642357
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Process for preparing modified proteins'
[patent_app_type] => B1
[patent_app_number] => 09/222625
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6838
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642357.pdf
[firstpage_image] =>[orig_patent_app_number] => 09222625
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222625 | Process for preparing modified proteins | Dec 28, 1998 | Issued |
Array
(
[id] => 1601774
[patent_doc_number] => 06476190
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Process for preparing modified proteins'
[patent_app_type] => B1
[patent_app_number] => 09/222069
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6807
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/476/06476190.pdf
[firstpage_image] =>[orig_patent_app_number] => 09222069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222069 | Process for preparing modified proteins | Dec 28, 1998 | Issued |
| 09/219939 | HEPATITIS C INHIBITOR PEPTIDES | Dec 22, 1998 | Abandoned |
Array
(
[id] => 1508662
[patent_doc_number] => 06441212
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Silanol enzyme inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/194715
[patent_app_country] => US
[patent_app_date] => 1998-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16869
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441212.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194715
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194715 | Silanol enzyme inhibitors | Dec 16, 1998 | Issued |
Array
(
[id] => 252689
[patent_doc_number] => 07579323
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-08-25
[patent_title] => 'Hemiasterlin analogs'
[patent_app_type] => utility
[patent_app_number] => 09/581511
[patent_app_country] => US
[patent_app_date] => 1998-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8257
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579323.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581511
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581511 | Hemiasterlin analogs | Dec 12, 1998 | Issued |